PACE4-altCT isoform of proprotein convertase PACE4 as tissue and plasmatic biomarker for prostate cancer

The proprotein convertase PACE4 has demonstrated value as a viable therapeutic target in prostate cancer (PCa). A novel isoform named PACE4-altCT, which arises in neoplastic lesions, plays an important role in tumor progression and has been validated as a pharmacological target. With the discovery o...

Descripción completa

Detalles Bibliográficos
Autores principales: Couture, Frédéric, Wang, Luojun, Dufour, Frédérik, Chabot-Maheux, Keena, Ekindi Ndongo, Nadia, Sabbagh, Robert, Day, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9001653/
https://www.ncbi.nlm.nih.gov/pubmed/35410344
http://dx.doi.org/10.1038/s41598-022-09778-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9001653/
https://www.ncbi.nlm.nih.gov/pubmed/35410344
http://dx.doi.org/10.1038/s41598-022-09778-6

Ejemplares similares